Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nanotechnology|March 7, 2019
Nanostructured, ultrathin silver-based transparent electrode with broadband near-infrared plasmonic resonanceMartin Bauch, Theodoros Dimopoulos, Stephan Trassl
Optics Express|April 26, 2017
High performance and low cost transparent electrodes based on ultrathin Cu layerDavid Ebner, Martin Bauch, Theodoros Dimopoulos
Nanotechnology|June 16, 2017
Nanostructured as-deposited indium tin oxide thin films for broadband antireflection and light trappingImran Khan, Martin Bauch, Theodoros Dimopoulos, et al.
ACS Applied Energy Materials|April 18, 2025
Bayesian Optimization of Spray Parameters for the Deposition of Ga2O3-Cu2O HeterojunctionsMaximilian Wolf, Georg K H Madsen, Theodoros Dimopoulos
Nanoscale Advances|September 22, 2022
Ultrathin sputter-deposited plasmonic silver nanostructuresSelina Goetz, Martin Bauch, Theodoros Dimopoulos, et al.
Nanotechnology|June 26, 2020
Gentle plasma process for embedded silver-nanowire flexible transparent electrodes on temperature-sensitive polymer substratesLukas Kinner, Emil J W List-Kratochvil, Theodoros Dimopoulos
Nanomaterials (Basel, Switzerland)|February 9, 2024
Heterojunction Devices Fabricated from Sprayed n-Type Ga2O3, Combined with Sputtered p-Type NiO and Cu2OTheodoros Dimopoulos, Rachmat Adhi Wibowo, Stefan Edinger, et al.
RSC Advances|April 28, 2022
High performance organic light-emitting diodes employing ITO-free and flexible TiO /Ag/Al:ZnO electrodesLukas Kinner, Theodoros Dimopoulos, Giovanni Ligorio, et al.
Anticancer Research|November 11, 2006
Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancerConstantine S Mitsiades, John Bogdanos, Dimitrios Karamanolakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastasesMichael Koutsilieris, Constantine S Mitsiades, John Bogdanos, et al.
Pageof 2